Clinical Features of Adult Patients Admitted to Pediatric Wards in Japan

Nobuaki Michihata1, Hiroki Matsui1, Kiyohide Fushimi2

  • 1Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan.

Insights

Adult patients in pediatric wards often have chronic childhood conditions or adult diseases. A disease-oriented support system is crucial for these long-term pediatric care patients.

Area of Science:

  • Pediatric care
  • Internal medicine
  • Healthcare management

Background:

  • Pediatricians increasingly manage adult patients with chronic pediatric diseases.
  • Limited data exists on the characteristics of adult inpatients in pediatric settings.

Purpose of the Study:

  • To characterize adult patients admitted to Japanese pediatric wards.
  • To identify clinical details and diagnoses of this patient population.

Main Methods:

  • Analysis of a national inpatient database in Japan (April 2012-March 2013).
  • Inclusion of inpatients aged 19 years and older admitted to pediatric departments.
  • Examination of primary diagnoses and use of home medical devices.

Main Results:

  • 1.1% (4,729/417,352) of pediatric ward patients were adults (≥19 years).
  • Common diagnoses included malignancy, congenital heart disease, epilepsy, and cerebral palsy.
  • Over 35% of cerebral palsy patients used respiratory or nutritional support devices; >20% of adults ≥40 years had adult diseases.

Conclusions:

  • Adult patients in pediatric wards frequently present with adult-onset diseases.
  • Developing specialized support systems for adults with childhood-onset chronic conditions is essential.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
732
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
467
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
377
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
782
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
333